These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 30788686

  • 1. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
    Zhou M, Li Y, Lin S, Chen Y, Qian Y, Zhao Z, Fan H.
    Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-inducible factor-1α cooperates with histone Lys methylation to predict prognosis in esophageal squamous cell carcinoma.
    Shen X, Li Y, Xu Y, Liu M, Zhang Q, Yin R, Zhou M, Lin S, Fan H.
    Biomark Med; 2021 May; 15(7):509-522. PubMed ID: 33856264
    [Abstract] [Full Text] [Related]

  • 3. Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.
    Li Y, Guo D, Sun R, Chen P, Qian Q, Fan H.
    Dig Dis Sci; 2019 Feb; 64(2):439-446. PubMed ID: 30350241
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
    Xia R, Zhou R, Tian Z, Zhang C, Wang L, Hu Y, Han J, Li J.
    Arch Pathol Lab Med; 2013 Dec; 137(12):1761-9. PubMed ID: 24283856
    [Abstract] [Full Text] [Related]

  • 8. Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.
    Yokoyama Y, Matsumoto A, Hieda M, Shinchi Y, Ogihara E, Hamada M, Nishioka Y, Kimura H, Yoshidome K, Tsujimoto M, Matsuura N.
    Breast Cancer Res; 2014 Jun 22; 16(3):R66. PubMed ID: 24953066
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY, Chang JM, Jiang SS, Chen CH, Chang IS, Sheu BS, Lu PJ, Chang WL, Lai WW, Wang YC.
    Int J Med Sci; 2014 Jun 22; 11(8):779-87. PubMed ID: 24936140
    [Abstract] [Full Text] [Related]

  • 11. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
    Liu F, Gu L, Cao Y, Fan X, Zhang F, Sang M.
    Biomarkers; 2016 Jun 22; 21(1):80-90. PubMed ID: 26631178
    [Abstract] [Full Text] [Related]

  • 12. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W, Liu S, Dong Z, Guo Y, Ding C, Shen S, Liang J, Shan B.
    Clin Exp Metastasis; 2018 Feb 22; 35(1-2):53-68. PubMed ID: 29524086
    [Abstract] [Full Text] [Related]

  • 13. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
    Guo J, Yang Q, Wei S, Shao J, Zhao T, Guo L, Liu J, Chen J, Wang G.
    BMC Cancer; 2022 Jul 07; 22(1):745. PubMed ID: 35799142
    [Abstract] [Full Text] [Related]

  • 14. Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1.
    Klonou A, Korkolopoulou P, Gargalionis AN, Kanakoglou DS, Katifelis H, Gazouli M, Chlamydas S, Mitsios A, Kalamatianos T, Stranjalis G, Themistocleous MS, Papavassiliou KA, Sgouros S, Papavassiliou AG, Piperi C.
    Neurotherapeutics; 2021 Jul 07; 18(3):2073-2090. PubMed ID: 34296393
    [Abstract] [Full Text] [Related]

  • 15. piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B.
    Su JF, Zhao F, Gao ZW, Hou YJ, Li YY, Duan LJ, Lun SM, Yang HJ, Li JK, Dai NT, Shen FF, Zhou FY.
    Pathol Res Pract; 2020 Apr 07; 216(4):152848. PubMed ID: 32051106
    [Abstract] [Full Text] [Related]

  • 16. Bioinformatics Analysis Reveals a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma.
    Yang H, Chen Y, Huang X, Gu Y, Chen Z, Mao W.
    Int J Med Sci; 2024 Apr 07; 21(7):1213-1226. PubMed ID: 38818465
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma.
    Li KK, Mao CY, Zhang JG, Ma Q, Wang YJ, Liu XH, Bao T, Guo W.
    Thorac Cancer; 2019 Nov 07; 10(11):2071-2080. PubMed ID: 31496055
    [Abstract] [Full Text] [Related]

  • 18. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT, Yeo SY, Yin YX, Lin ZH, Lee HM, Xuan YH, Cui Y, Kim SH.
    PLoS One; 2016 Nov 07; 11(1):e0145807. PubMed ID: 26731558
    [Abstract] [Full Text] [Related]

  • 19. High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients' worse prognosis in human hepatocellular carcinomas.
    Qian Y, Li Y, Zheng C, Lu T, Sun R, Mao Y, Yu S, Fan H, Zhang Z.
    Cancer Genet; 2020 Jul 07; 245():17-26. PubMed ID: 32534446
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.